152 related articles for article (PubMed ID: 15124685)
1. Curative therapeutic approaches to APL.
Tallmann MS
Ann Hematol; 2004; 83 Suppl 1():S81-2. PubMed ID: 15124685
[TBL] [Abstract][Full Text] [Related]
2. Treatment concepts of acute promyelocytic leukemia.
Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute promyelocytic leukaemia.
Fenaux P; Chomienne C; Degos L
Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929
[TBL] [Abstract][Full Text] [Related]
4. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
5. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
6. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
7. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
[TBL] [Abstract][Full Text] [Related]
9. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
[TBL] [Abstract][Full Text] [Related]
10. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
[TBL] [Abstract][Full Text] [Related]
11. Early relapse after non myeloablative allogeneic stem cell transplantation in a patient with acute promyelocytic leukemia in complete molecular remission.
Tavernier E; Thomas X
Indian J Cancer; 2003; 40(4):140-3. PubMed ID: 14716110
[TBL] [Abstract][Full Text] [Related]
12. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
[TBL] [Abstract][Full Text] [Related]
13. [Hematopoietic stem cell transplantation in the second or later complete remission in acute promyelocytic leukemia initially treated with all-trans retinoic acid].
Fujita H; Nakaya A; Kato J; Tachibana T; Takemura S; Hyo R; Kawano T; Tanaka M; Taguchi J; Maruta A; Fujimaki K; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1095-9. PubMed ID: 16440769
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia: current strategies for the treatment of newly diagnosed disease.
Sirulnik LA; Stone RM
Clin Adv Hematol Oncol; 2005 May; 3(5):391-7, 429. PubMed ID: 16167012
[TBL] [Abstract][Full Text] [Related]
15. The role of bone marrow transplantation in acute promyelocytic leukemia.
Nabhan C; Mehta J; Tallman MS
Bone Marrow Transplant; 2001 Aug; 28(3):219-26. PubMed ID: 11535988
[TBL] [Abstract][Full Text] [Related]
16. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
17. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
Wang Z; Sun G; Shen Z; Chen S; Chen Z
Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
[TBL] [Abstract][Full Text] [Related]
18. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
Tallman MS; Abutalib SA; Altman JK
Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of acute myeloid leukemias in the adult in relapse].
Thomas X; Le QH
Bull Cancer; 2002 Sep; 89(9):795-807. PubMed ID: 12368132
[TBL] [Abstract][Full Text] [Related]
20. Differentiating therapy in acute myeloid leukemia.
Tallman MS
Leukemia; 1996 Aug; 10(8):1262-8. PubMed ID: 8709629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
